Clinical Trial Update: A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure [Phase 3]

View source ↗

Summary

Phase 3 trial to evaluate the safety and efficacy of Baxdrostat in combination with Dapagliflozin. The study aims to assess renal outcomes and cardiovascular mo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hypertension

Drugs mentioned

• Baxdrostat (Baxdrostat)
• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Kidney Disease and Hypertension | Phase 3 | Status: RECRUITING